Associate Professor, Division Gastroenterology, Hepatology and Nutrition, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA, USA.
Lead Biostatistician, Research Administration, Children's Medical Center Dallas, Dallas, TX, USA.
J Cyst Fibros. 2022 Sep;21(5):830-836. doi: 10.1016/j.jcf.2022.05.003. Epub 2022 May 16.
Concerns related to stool consistency are common in the first year of life among children with cystic fibrosis (CF). However, normal stool patterns for infants with CF have not been described.
Secondary analysis was completed from the previously described BONUS cohort which followed 231 infants with CF through the first 12 months of life. Pain, stool category, stool frequency, feeding type, PERT dose, acid suppression medication, antibiotics usage, stool softener usage and fecal calprotectin were described at 3, 6, and 12 months. Repeated measure ANOVA was used to test the difference in mean stool number. Generalized linear mixed models were used to investigate the relationship between stool characteristics and various factors.
The frequency of constipation was stable throughout the first year of life (10-13%) while watery stool significantly decreased from 21.3% at 3 months to 5.8% at 12 months (p=<0.001). The number of stools at months 6 (mean=2.40) and 12 (mean=2.50) are significantly lower than in month 3 (mean=2.83), p<0.025. Exclusive breast feeding was associated with an increased risk for constipation (OR=2.64 [1.60-4.37], p = 0.002) while exclusive formula feeding and acid suppression was associated with decreased risk for constipation (OR=0.40 [0.26-0.61], p=<0.0001 and OR=0.59 [0.39-0.89], p = 0.01 respectively). Pain was not significantly associated with stool consistency.
Stool frequency and consistency evolves in infant with CF in a fashion similar to that reported in non-CF infants over the first year. Constipation was not associated with pain and was less common among infants receiving acid suppression or exclusively formula feeding.
囊性纤维化(CF)患儿在生命的第一年常出现与粪便稠度相关的问题。然而,尚未对 CF 患儿的正常粪便模式进行描述。
对先前描述的 BONUS 队列进行二次分析,该队列对 231 例 CF 婴儿进行了为期 12 个月的随访。在 3、6 和 12 个月时描述了疼痛、粪便分类、粪便频率、喂养类型、PERT 剂量、抑酸药物、抗生素使用、粪便软化剂使用和粪便钙卫蛋白。采用重复测量方差分析检验平均粪便数量的差异。采用广义线性混合模型探讨粪便特征与各种因素的关系。
便秘的频率在整个第一年保持稳定(10-13%),而稀便则从 3 个月时的 21.3%显著下降到 12 个月时的 5.8%(p<0.001)。6 个月(均值=2.40)和 12 个月(均值=2.50)的粪便数量明显低于 3 个月(均值=2.83),p<0.025。纯母乳喂养与便秘风险增加相关(OR=2.64 [1.60-4.37],p=0.002),而纯配方奶喂养和抑酸治疗与便秘风险降低相关(OR=0.40 [0.26-0.61],p<0.0001 和 OR=0.59 [0.39-0.89],p=0.01)。疼痛与粪便稠度无显著相关性。
CF 患儿的粪便频率和稠度在第一年的变化与非 CF 婴儿的变化相似。便秘与疼痛无关,在接受抑酸治疗或纯配方奶喂养的婴儿中较少见。